MedCity News
AUGUST 7, 2024
Cigna is distributing about $3 million to 22 nonprofits addressing youth mental health. Over the next three years, the company is allocating $9 million total. The post Cigna Distributes Grants to 22 Nonprofits Focused on Youth Mental Health appeared first on MedCity News.
Fierce Pharma
AUGUST 7, 2024
The first horse carrying Novartis’ immunoglobulin A nephropathy (IgAN) troika has crossed the FDA finish line. | The first horse carrying Novartis’ immunoglobulin A nephropathy (IgAN) troika has crossed the FDA finish line.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MedCity News
AUGUST 7, 2024
WebMD Ignite recently released new products aimed at helping providers close financial gaps by targeting a specific problem: revenue leakage. The post WebMD’s New Tech Targets Referral Leakage as Providers Continue to Battle Rising Costs appeared first on MedCity News.
Fierce Pharma
AUGUST 7, 2024
As multiple drugmakers race to bring novel, levodopa-based Parkinson’s disease treatments to the market, New Jersey’s Amneal has taken home the gold in the U.S. | Late Wednesday, the FDA granted approval to Amneal’s Crexont—formerly known as IPX203—which is an oral, extended-release formulation of the common Parkinson’s disease (PD) drugs carbidopa/levodopa (CD/LD).
Speaker: Jesse Hunter and Brynn Chadwick
Today’s buyers expect more than generic outreach–they want relevant, personalized interactions that address their specific needs. For sales teams managing hundreds or thousands of prospects, however, delivering this level of personalization without automation is nearly impossible. The key is integrating AI in a way that enhances customer engagement rather than making it feel robotic.
MedCity News
AUGUST 7, 2024
Health plans can reduce late payment interest by up to 25% year over year by focusing on three critical areas. The post The Critical Imperative for Health Plans to Tackle Late Payment Interest appeared first on MedCity News.
Pharma Rep Focus brings together the best content for pharma rep professionals from the widest variety of industry thought leaders.
MedCity News
AUGUST 7, 2024
G1 Therapeutics turned research from the University of North Carolina at Chapel Hill into novel cancer drug Cosela, which is approved in the U.S. and China. Pharmacosmos says its G1 acquisition will enable Cosela to reach more lung cancer patients around the world. The post Path Forward for Cancer Biotech G1 Therapeutics Is $405M Acquisition by Pharmacosmos appeared first on MedCity News.
Fierce Pharma
AUGUST 7, 2024
On the rocky road to ensuring access to gene therapy Casgevy in the U.K., Vertex and CRISPR Therapeutics are making inroads by securing a thumbs up from England’s National Institute for Health and | The cost-effectiveness regulator recommended government funding for the groundbreaking gene-editing therapy in one of its two approved indications.
MedCity News
AUGUST 7, 2024
As many as 25 percent of all ER visits by older adults come from people with dementia. A better alternative is urgent medical response at home – working with seniors in their own familiar place without the pressures, distractions, or costs of a bustling ER. Or the endless wait times. The post Pandemic Lesson: How to Move Healthcare From the Emergency Room to the Living Room appeared first on MedCity News.
Fierce Pharma
AUGUST 7, 2024
Amgen’s roller coaster ride known as Tepezza is ascending again. Is the thyroid eye disease (TED) treatment finally gaining momentum that is sustainable? | Amgen’s roller coaster ride known as Tepezza is ascending again. Is the thyroid eye disease (TED) treatment finally gaining momentum that is sustainable? In the second quarter, Tepezza generated $479 million in sales for an increase of 8% year over year and 13% sequentially.
Advertiser: ZoomInfo
Incorporating generative AI (gen AI) into your sales process can speed up your wins through improved efficiency, personalized customer interactions, and better informed decision- making. Gen AI is a game changer for busy salespeople and can reduce time-consuming tasks, such as customer research, note-taking, and writing emails, and provide insightful data analysis and recommendations.
Evolve Your Success
AUGUST 7, 2024
Unlock the secrets to building trust-based relationships in medical sales and elevate your career in orthopedics with insights from Dr. Diego Lima of Atlantis Orthopedics. Dr. Lima takes us through his journey from medical school to becoming a prominent orthopedic surgeon, emphasizing the critical role of teamwork and meticulous planning. We’ll explore the structured yet unpredictable nature of his workweek, where he juggles office days, surgeries, and research projects while managing a co
Fierce Pharma
AUGUST 7, 2024
In a deal worth approximately $405 million, Danish drugmaker Pharmacosmos has agreed to acquire G1 Therapeutics and the latter company's flagship product Cosela. | The companies will team up to expand the reach of G1's Cosela, which is used to reduce bone marrow damage associated with certain chemotherapy regimens.
PharmaVoice
AUGUST 7, 2024
Arialys Therapeutics is developing a preclinical treatment for a rare autoimmune encephalitis that mimics psychosis.
Fierce Pharma
AUGUST 7, 2024
Despite a rocky start to the year for Merck KGaA’s contract development and manufacturing group, the German company is finding some reason to be optimistic about its recent performance. | After a rocky start to the year, Merck KGaA’s CDMO and process solutions units appear to be nearing a comeback.
Speaker: Kevin Burke
AI is reshaping marketing and sales, empowering professionals to work smarter, faster, and more effectively. This webinar will provide a practical introduction to AI, focusing on its current applications, transformative potential, and strategies for successful implementation in your organization. Using real-world examples and actionable insights, we’ll examine how businesses are leveraging AI to increase efficiency, enhance personalization, and drive measurable results.
PharmaVoice
AUGUST 7, 2024
The biotech boasts some Big Pharma backers that drove a $100 million fundraising effort in July to take its depression drug into a mid-stage study.
Fierce Pharma
AUGUST 7, 2024
With supplies of its star obesity med Wegovy now largely unfettered, Novo Nordisk is dialing up its sales expectations for the remainder of the year—and teasing the potential for net price declines | With supplies of its star obesity med Wegovy now largely unfettered, Novo Nordisk is dialing up its sales expectations for the remainder of the year—and teasing the potential for net price declines on the immensely popular GLP-1.
MedCity News
AUGUST 7, 2024
The path forward is clear: employers must evaluate their health plan the same way they do their Saturday shopping excursion. The post What Healthcare Can Learn from Costco appeared first on MedCity News.
Fierce Pharma
AUGUST 7, 2024
In its first full quarter on the market, Madrigal Pharmaceuticals’ Rezdiffra, the first treatment for metabolic dysfunction-associated steatohepatitis (MASH), achieved sales of $14.6 million. | In its first full quarter on the market, Madrigal Pharmaceuticals’ Rezdiffra, the first treatment for metabolic dysfunction-associated steatohepatitis (MASH), achieved sales of $14.6 million.
Advertiser: ZoomInfo
In today’s ultra-competitive markets, it’s no longer enough to wait for buyers to show obvious signs of interest. Instead, sales teams must be proactive, identifying and acting on nuanced buyer behaviors — often before prospects are fully ready to make a purchase. In this eBook from ZoomInfo & Sell Better, learn 10 actionable ways to use these buyer signals to transform your sales strategy and close deals faster.
pharmaphorum
AUGUST 7, 2024
BioMarin Pharma has decided not to divest its haemophilia A gene therapy Roctavian but is reining back its ambitions for the business, for now
PharmaTimes
AUGUST 7, 2024
Type 1 diabetes accounts for approximately 10% of diabetes cases in the UK
pharmaphorum
AUGUST 7, 2024
Weaker sales of obesity drug Wegovy cause a dip in Novo Nordisk's share price, but CEO says volume growth is strong and will accelerate in second half
PharmaTimes
AUGUST 7, 2024
Researchers aim to explore and investigate axonal dysfunction in neurodegeneration
Advertisement
What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.
Salesforce
AUGUST 7, 2024
When a customer isn’t happy, businesses tend to scramble and try to turn things around. However, reactive marketing is like a Band-Aid. It might stop the immediate hurt or frustration, but it doesn’t fix the underlying problem. Eventually, the wound could be reopened. The way around this is to build customer loyalty with an “always on” marketing strategy.
Pharmaceutical Commerce
AUGUST 7, 2024
The latest news for pharma industry insiders.
pharmaphorum
AUGUST 7, 2024
A non-opioid drug for pain developed by UK biotech Levicept, with a new mechanism of action, has shown it can reduce pain associated with osteoarthritis in a phase 2 trial.Neurotrophin-3 (NT-3) inhibitor LEVI-04 hit all its primary and secondary objectives in the trial, which enrolled 510 patients with moderate-to-severe osteoarthritis of the knee, raising the hope it could become a non-addictive option for patients needing chronic pain relief.
Pharmaceutical Commerce
AUGUST 7, 2024
Why it is important for organizations to set long-term goals when planning for a sustainable future?
Advertiser: ZoomInfo
As prospects define their problem, search for solutions, and even change jobs, they are generating high-value signals that the best go-to-market teams can leverage to close more deals. This is where signal-based selling comes into play. ZoomInfo CEO Henry Schuck recently broke down specific ways to put four key buying signals into action with the experts from 30 Minutes to President’s Club.
pharmaphorum
AUGUST 7, 2024
Around 14,000 women in England may soon be able to access osteoporosis drug Eladynos from Theramex after NICE backed NHS use
Pharmaceutical Commerce
AUGUST 7, 2024
In an interview with Pharma Commerce Editor Nicholas Saraceno, Michael Rowe, Two Labs’ Sr. Director, DSCSA/Serialization Compliance Services, Two Labs, offers a brief overview of the Drug Supply Chain Security Act.
pharmaphorum
AUGUST 7, 2024
FDA approves Servier's IDH 1/2 inhibitor vorasidenib as the first targeted therapy for incurable brain cancer glioma
Expert insights. Personalized for you.
284 
Let's personalize your content